Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
Multimedia
Popular
STAT Plus

Job Board
About Us

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Pharma

Taking stock of the drug industry, from the lab to the medicine chest

In the Lab

This tech won the Nobel Prize — and drug developers are avidly putting it to use

By Andrew Joseph

Pharmalot

McCaskill files bill to block maneuvers like Allergan’s patent deal, infuriating the Mohawks

By Ed Silverman

advertisement

Pharmalot

Insys to pay $500,000 to Massachusetts for illegal marketing of potent painkiller

By Ed Silverman

advertisement

Pharmalot

Sanofi and Regeneron score a big win over Amgen in the cholesterol wars

By Ed Silverman

Pharma

Half the cancer drugs approved in Europe recently don’t significantly help patients

By Associated Press

Pharmalot

Biotech execs still fret about pressure to bring down drug prices — but fears are starting to ease

By Ed Silverman

Pharmalot

Pharmalittle: Pharma loses fight over curbing U.K. drug costs; Cigna dumps OxyContin

By Ed Silverman

advertisement

Pharma

Cigna says it won’t cover OxyContin prescriptions through employer plans

advertisement

Pharmalot

What are the implications of a generic Teva MS drug? Here’s what the wags say

By Ed Silverman

Pharmalot

Japan scolds Bayer for promotional violations and failing to report side effects

By Ed Silverman

Pharmalot

Pharmalittle: Teva faces generics for a key drug; French police search Merck KGgA plant

By Ed Silverman

Pharmalot

House probes Allergan deal with Mohawks, but drug maker claims foul

By Ed Silverman

Politics

House lawmakers unsure of Senate right-to-try bill, as Gottlieb suggests narrower scope

By Erin Mershon

Pharmalot

Pfizer loses battle to keep Medicaid rebate data hidden from Texas lawmakers

By Ed Silverman

Pharmalot

Lawmaker urges pharma trade group to review Allergan patent deal with Mohawks

By Ed Silverman

Pharmalot

Pharmalittle: Shire files antitrust suit against Allergan; FDA looks to boost generic competition

By Ed Silverman

Pharma

This Alzheimer’s patient stars in a multimillion-dollar ad campaign for pharma. He may soon be homeless

By Rebecca Robbins

Pharmalot

The U.S. would pay an extra $10.7 billion without generic Allergan drug

By Ed Silverman

Pharmalot

4 ways the Trump tax changes could help the pharmaceutical industry

By Ed Silverman

Pharmalot

Former Glaxo private eyes lose their lawsuit against the drug maker

By Ed Silverman

Pharma

5 ways pharma is misleading the public on the cost of prescription drugs

By Jay Hancock — Kaiser Health News

Pharmalot

Pharmalittle: Cher says Soon-Shiong tricked her; will Dynavax sell its hep B vaccine?

By Ed Silverman

Pharmalot

Maryland law that punishes generic price gouging can proceed

By Ed Silverman

Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Lilly creates new top team, Amerisource settles criminal charges

By Ed Silverman

Pharmalot

Canada orders Alexion to lower an ‘excessive’ price for a rare disease drug

By Ed Silverman

Pharmalot

To lower costs, Massachusetts seeks to limit Medicaid drug coverage

By Ed Silverman

Politics

Demanding action from Trump on MS drug prices, Elijah Cummings takes to Twitter

Biotech

FDA panel votes no on PTC’s Duchenne muscular dystrophy drug

By Adam Feuerstein

« Previous Page

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

Industry

Leave this field empty if you're human:

Sign up for our morning rounds newsletter

Leave this field empty if you're human:

Reporting from the frontiers of health and medicine

About Us
Contact Us
The STAT Team
STAT Wunderkinds
Awards for STAT
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT

X